Europe Eclinical Solutions Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
1 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 6,039.37 |
 CAGR |
% |
| Major Markets Players |
>欧洲电子临床解决方案市场，按产品（电子数据采集和临床试验数据管理系统、临床试验管理系统、临床分析平台、护理协调医疗记录 (CCMR)、随机化和试验供应管理、临床数据集成平台、电子临床结果评估解决方案、安全解决方案、电子试验主文件系统、监管信息管理解决方案等）、交付模式（Web 托管（按需）解决方案、许可企业（本地）解决方案和基于云的 (SAAS) 解决方案）、临床试验阶段（第一阶段、第二阶段、第三阶段和第四阶段）、组织规模（小型、中型和大型）、用户设备（台式机、平板电脑、手持 PDA 设备、智能手机等）、最终用户（制药和生物制药公司、合同研究组织、咨询服务公司、医疗器械制造商、医院和学术研究机构）、行业趋势和预测到 2030 年。
欧洲电子临床解决方案市场分析和规模
欧洲电子临床解决方案市场比较分散，因为它由许多全球参与者组成，例如 Oracle、IQVIA Inc.、Dassault Systemes 和 Clario 等。这些公司的存在为整个地区的系统服务和软件提供了具有竞争力的价格。由于这些参与者在地区和国际层面的存在，供应商和制造商提供的产品具有不同的规格和特点，适合所有预算。电子数据采集 (EDC) 系统和基于云的系统的日益普及正在推动市场增长。此外，对以患者为中心的临床试验的日益关注预计将推动市场增长。
Data Bridge Market Research 分析称，到 2030 年，欧洲电子临床解决方案市场价值预计将达到 60.3937 亿美元，预测期内复合年增长率为 13.3%。本市场报告还深入介绍了定价分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2015 – 2020） |
|
定量单位 |
收入（百万美元）、销量（单位）和定价（美元） |
|
涵盖的领域 |
By Product (Electronic Data Capture and Clinical Trial Data Management Systems, Clinical Trial Management Systems, Clinical Analytics Platforms, Care Coordination Medical Records (CCMR), Randomization and Trial Supply Management, Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Electronic Trial Master File Systems, Regulatory Information Management Solutions, and Others), Delivery Mode (Web-Hosted (On-Demand) Solutions, Licensed Enterprise (On-Premises) Solutions, and Cloud-Based (SAAS) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Small & Medium and Large), User Device (Desktop, Tablet, Handheld PDA Device, Smart Phone, and Others), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Research Organizations, Consulting Service Companies, Medical Device Manufacturers, Hospitals, and Academic Research Institutes) |
|
Countries Covered |
Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium, and the Rest of Europe, |
|
Market Players Covered |
Oracle, Signant Health, MaxisIT, Paraxel International Corporation, Dassault Systemes, Clario, Mednet, OpenClinica, LLC, 4G Clinical, Veeva Systems, Saama Technologies, LLC, Anju, Castor, Medrio, Inc., ArisGlobal, Merative, Advarra, eClinical Solutions, LLC, Y-Prime LLC, RealTime Software Solutions LLC, Quretec, Research Manager, Datatrack Int., and IQVIA Inc.
|
Market Definition
The goal of e-clinical solutions is to revolutionize the field of clinical research. The clinical management organization is trying to improve the effectiveness, efficiency, and accessibility of clinical research data to treat patients more quickly. The idea behind the creation of eClinical Solutions was to pinpoint the problems with clinical research data, fix them, and offer creative solutions to make clinical trial data useful and simple to obtain, as well as to facilitate the standardization, reporting, and operation of the clinical research domain. The rising adoption and growing focus towards the e clinical solutions and software are expected to drive market growth.
The e-clinical solutions, such as electronic data capture (EDC), electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic trial master file (eTMF) systems, are software programs used in clinical research to manage clinical data. However, strict regulations and standards for the approval of clinical trial studies and product approvals are expected to restrain market growth.
Europe e-Clinical Solutions Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
Increasing R&D activities and corresponding expenditure
Research & development is crucial in all industries, including life science and healthcare. The life science industry carries out extensive research and development to generate revenue and often brings results that embrace saving or enhancing a patient's life. Drug development requires going through clinical trials to check clinical data analysis and review its study and new data insights.
The e-clinical solutions are used for comprehensive data review, automating the data transformation process, and analytics to accelerate timelines. Pharmaceutical and biopharmaceutical companies conduct many clinical trials to complete successful drug or biologic development. Pharmaceutical and biopharmaceutical companies have increased their focus on research and development, raising the demand for e-clinical solutions.
Improved healthcare infrastructure and establishment of advanced laboratories
Infrastructure is a key pillar supporting the fundamental aim of promoting improved standards of care and well-being for all patients, together with a good healthcare system experience. In parallel, the healthcare system and staff must support effective health promotion, prevention, and self-care of the whole population.
Infrastructure must integrate the hospital, as the acute and in-patient care center, into the broader healthcare system. It should facilitate the seven domains of quality patient experience, effectiveness, efficiency, timeliness, safety, equity, and sustainability. Infrastructure includes the built environment and supporting elements such as equipment, access, information technology (IT), systems and processes, sustainability initiatives, and staff. This improved healthcare infrastructure and staff more opportunities for e-clinical solutions to grow and give better results.
OPPORTUNITY
Increasing investments by various governments in clinical trials
Clinical trial funding comes from various sources, including the government, commercial investors, nonprofit organizations, academic institutions, and other research organizations. Historically, the National Institutes of Health (NIH) has made the biggest government investments in fundamental drug development research. The defense advanced research agency (DARPA) has also contributed to the discovery stage by accepting a few relatively high-risk biologic initiatives. State governments are also increasingly taking the lead in this area, partly due to the public's frustration with the lengthy discovery process. Thus, government initiatives and investments toward discovering new drugs with trial studies are expected to create an opportunity for market growth.
RESTRAINT / CHALLENGE
Data Safety and Privacy issues
Information systems are heavily concerned with privacy and security. Access to individual health information is made possible by digitalizing healthcare services from any electronic device with an internet connection anywhere globally. Users typically are unaware of how their data is handled. Healthcare data on the cloud has caught the attention of hackers, who target systems to launch attacks and steal sensitive data in exchange for financial benefit.
Data breaches have been common since 2019, over 50 million electronic medical records have been hacked in 2021, and the number of security breaches was predicted to increase every year. The creation of inter-jurisdictional data-sharing agreements and the storage and manipulation of data holdings are significantly hampered by concerns about personal privacy and information confidentiality and the recent enactment of privacy and confidentiality legislation across the provinces and territories (exceptionally patient records). Thus, it is a restraint for the Europe e-clinical solutions market and is expected to hamper the market growth.
Post-COVID-19 Impact on the Europe e-Clinical Solutions Market
COVID-19 created a positive impact on the Europe e-clinical solutions market. The lockdown restriction led to the emergence of various opportunities such as drug development, EMR and EHR application installation, and many others.
However, increasing government support and advanced and innovative techniques are expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel market growth. Also, the growth has been high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve the trial study techniques. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In April 2023, the Medidata subsidiary of Dassault Systèmes announced Lambda Therapeutics is deploying Medidata's cloud-based clinical products, Rave EDC, Rave RTSM, and Rave Imaging, according to a statement from Dassault Systèmes subsidiary Medidata. Automating and optimizing data management operations and securely delivering higher-quality data for quicker insights will further improve clinical trial productivity. This has aided the business in promoting its offerings across the globe
- In March 2023, Clario has launched a cloud-based Image Viewer tool that helps the Sponsors and CROs to see the images of their clinical trials. Previously, several organizations had to participate in the image transfer procedure to see photos for a clinical trial. This complicated the already risky process and increased the possibility of delays and mistakes. This has aided the business in growing its service offering
Europe e-Clinical Solutions Market Scope
欧洲电子临床解决方案市场根据产品、交付模式、临床试验阶段、组织规模、用户设备和最终用户分为六个显著的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和见解，帮助他们做出战略决策，确定核心市场应用。
产品
- 电子数据采集和临床数据管理系统
- 临床试验管理系统
- 临床分析平台
- 护理协调医疗记录 (CCMR)
- 随机化和试验供应管理
- 临床数据集成平台
- 电子临床结果评估解决方案
- 安全解决方案
- 电子审判主文件系统
- 监管信息管理解决方案
- 其他的
根据产品，市场细分为电子数据采集和临床数据管理、临床试验管理系统、临床分析平台、护理协调医疗记录 (CCMR)、随机化和试验供应管理、临床数据集成平台、电子临床结果评估解决方案、安全解决方案、电子试验主文件系统、监管信息管理解决方案等。
交付方式
- Web 托管（按需）解决方案
- 许可企业（本地）解决方案
- 基于云的（SAAS）解决方案
根据交付模式，市场细分为网络托管（按需）解决方案、许可企业（本地）解决方案和基于云（SAAS）的解决方案。
临床试验阶段
- 第一阶段
- 第二阶段
- 第三阶段
- 第四阶段
根据临床试验阶段，市场分为 I 期、II 期、III 期和 IV 期。
组织规模
- 小型和中型
- 大的
根据组织规模，市场分为小型、中型和大型。
用户设备
- 桌面
- 药片
- 手持式 PDA 设备
- 手机
- 其他的
根据用户设备，市场分为台式机、平板电脑、手持 PDA 设备、智能手机和其他。
最终用户
- 制药和生物制药公司
- 合同研究组织
- 咨询服务公司
- 医疗器械制造商
- 医院
- 学术研究机构
根据最终用户，市场细分为制药和生物制药公司、合同研究组织、咨询服务公司、医疗器械制造商、医院和学术研究机构。
欧洲电子临床解决方案市场区域分析/见解
对欧洲电子临床解决方案市场进行分析，市场规模信息基于产品、交付模式、临床试验阶段、组织规模、用户设备和最终用户。
本市场报告涵盖的国家包括德国、法国、英国、意大利、西班牙、荷兰、俄罗斯、瑞士、土耳其、比利时和欧洲其他地区。
由于电子数据采集系统和基于云的解决方案的日益普及，德国有望在欧洲地区占据主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战以及销售渠道的影响。
竞争格局和欧洲电子临床解决方案市场份额分析
欧洲电子临床解决方案市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对市场的关注有关。
欧洲电子临床解决方案市场的一些主要市场参与者包括 Oracle、Signant Health、MaxisIT、Paraxel International Corporation、Dassault Systemes、Clario、Mednet、OpenClinica, LLC、4G Clinical、Veeva Systems、Saama Technologies, LLC、Anju、Castor、Medrio, Inc.、ArisGlobal、Merative、Advarra、eClinical Solutions, LLC、Y-Prime LLC 和 RealTime Software Solutions LLC 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER'S FIVE FORCES MODEL
4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS
4.3 USE CASES
5 VALUE CHAIN ANALYSIS
6 EUROPE E-CLINICAL SOLUTIONS MARKET: REGULATIONS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS
7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE
7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES
7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES
7.2 RESTRAINTS
7.2.1 DATA SAFETY AND PRIVACY ISSUES
7.2.2 LACK OF SKILLED PROFESSIONALS
7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES
7.3 OPPORTUNITIES
7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS
7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS
7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS
7.4 CHALLENGES
7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS
7.4.2 HIGH IMPLEMENTATION COSTS
8 EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS
8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT
8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS
8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS
8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS
8.7 SAFETY SOLUTIONS
8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS
8.9 CLINICAL DATA INTEGRATION PLATFORMS
8.1 CLINICAL ANALYTICS PLATFORMS
8.11 CARE COORDINATION MEDICAL RECORD (CCMR)
8.12 OTHERS
9 EUROPE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE
9.1 OVERVIEW
9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS
9.3 CLOUD-BASED (SAAS) SOLUTIONS
9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS
10 EUROPE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE
10.1 OVERVIEW
10.2 PHASE III
10.3 PHASE I
10.4 PHASE II
10.5 PHASE IV
11 EUROPE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE
11.1 OVERVIEW
11.2 MEDIUM AND SMALL
11.3 LARGE
12 EUROPE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE
12.1 OVERVIEW
12.2 DESKTOP
12.3 TABLET
12.4 SMART PHONE
12.5 HANDHELD PDA DEVICE
12.6 OTHERS
13 EUROPE E-CLINICAL SOLUTIONS MARKET, BY END USER
13.1 OVERVIEW
13.2 CONTRACT RESEARCH ORGANIZATIONS
13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
13.4 MEDICAL DEVICE MANUFACTURERS
13.5 HOSPITAL
13.6 CONSULTING SERVICE COMPANIES
13.7 ACADEMIC RESEARCH INSTITUTES
14 EUROPE E-CLINICAL SOLUTIONS MARKET, BY REGION
14.1 EUROPE
14.1.1 GERMANY
14.1.2 FRANCE
14.1.3 U.K.
14.1.4 ITALY
14.1.5 SPAIN
14.1.6 RUSSIA
14.1.7 TURKEY
14.1.8 NETHERLANDS
14.1.9 BELGIUM
14.1.10 SWITZERLAND
14.1.11 REST OF EUROPE
15 EUROPE E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: EUROPE
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ORACLE
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 DASSAULT SYSTEMES
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 CLARIO
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 VEEVA SYSTEMS
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 ARISEUROPE
17.5.1 COMPANY SNAPSHOT
17.5.2 COMPANY SHARE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENTS
17.6 4G CLINICAL
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 ADVARRA.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANJU
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 CASTOR.
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 DATATRAK INT.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 ECLINICAL SOLUTIONS LLC.
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 IQVIA INC
17.12.1 COMPANY SNAPSHOT
17.12.2 REVENUE ANALYSIS
17.12.3 PRODUCT PORTFOLIO
17.12.4 RECENT DEVELOPMENTS
17.13 MAXISIT
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 MEDNET
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
17.15 MEDRIO, INC.
17.15.1 COMPANY SNAPSHOT
17.15.2 PRODUCT PORTFOLIO
17.15.3 RECENT DEVELOPMENTS
17.16 MERATIVE
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENT
17.17 OPENCLINICA, LLC
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENT
17.18 PAREXEL INTERNATIONAL CORPORATION
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 QURETEC
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENT
17.2 REALTIME SOFTWARE SOLUTIONS, LLC
17.20.1 COMPANY SNAPSHOT
17.20.2 PRODUCT PORTFOLIO
17.20.3 RECENT DEVELOPMENT
17.21 RESEARCH MANAGER
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 SAAMA TECHNOLOGIES, LLC
17.22.1 COMPANY SNAPSHOT
17.22.2 PRODUCT PORTFOLIO
17.22.3 RECENT DEVELOPMENT
17.23 SIGNANT HEALTH
17.23.1 COMPANY SNAPSHOT
17.23.2 PRODUCT PORTFOLIO
17.23.3 RECENT DEVELOPMENT
17.24 Y-PRIME, LLC.
17.24.1 COMPANY SNAPSHOT
17.24.2 PRODUCT PORTFOLIO
17.24.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 THE COSTS OF IMPLEMENTATION ARE AS FOLLOWS, ACCORDING TO SIMPLETRIALS:
TABLE 2 ACCORDING TO ECLINICAL WORKS – ECLINICAL OFFERS TWO ENTERPRISE PRICING PACKAGES:
TABLE 3 EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 4 EUROPE ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 EUROPE RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 EUROPE CLINICAL TRIAL MANAGEMENT SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 EUROPE ELECTRONIC TRIAL MASTER FILE SYSTEMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 8 EUROPE ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 EUROPE SAFETY SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 EUROPE REGULATORY INFORMATION MANAGEMENT SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 EUROPE CLINICAL DATA INTEGRATION PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE CLINICAL ANALYTICS PLATFORMS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 13 EUROPE CARE COORDINATION MEDICAL RECORD (CCMR) IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 14 EUROPE OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 EUROPE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 16 EUROPE WEB-HOSTED (ON-DEMAND) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 EUROPE CLOUD-BASED (SAAS) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 EUROPE LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 EUROPE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 20 EUROPE PHASE III IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 EUROPE PHASE I IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 EUROPE PHASE II IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 EUROPE PHASE IV IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 24 EUROPE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 25 EUROPE MEDIUM AND SMALL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 EUROPE LARGE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 EUROPE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 28 EUROPE DESKTOP IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 EUROPE TABLET IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 EUROPE SMART PHONE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 EUROPE HANDHELD PDA DEVICE IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 EUROPE OTHERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 EUROPE E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 34 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 EUROPE MEDICAL DEVICE MANUFACTURERS IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 EUROPE HOSPITAL IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 EUROPE CONSULTING SERVICE COMPANIES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 EUROPE ACADEMIC RESEARCH INSTITUTES IN E-CLINICAL SOLUTIONS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 EUROPE E-CLINICAL SOLUTIONS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 41 EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 42 EUROPE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 43 EUROPE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 44 EUROPE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 45 EUROPE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 46 EUROPE E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 47 GERMANY E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 48 GERMANY E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 49 GERMANY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 50 GERMANY E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 51 GERMANY E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 52 GERMANY E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 FRANCE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 54 FRANCE E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 55 FRANCE E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 56 FRANCE E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 57 FRANCE E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 58 FRANCE E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 59 U.K. E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 60 U.K. E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 61 U.K. E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 62 U.K. E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 63 U.K. E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 64 U.K. E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 65 ITALY E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 66 ITALY E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 67 ITALY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 68 ITALY E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 69 ITALY E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 70 ITALY E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 SPAIN E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 72 SPAIN E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 73 SPAIN E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 74 SPAIN E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 75 SPAIN E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 76 SPAIN E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 77 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 78 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 79 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 80 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 81 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 82 RUSSIA E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 83 TURKEY E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 84 TURKEY E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 85 TURKEY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 86 TURKEY E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 87 TURKEY E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 88 TURKEY E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 89 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 90 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 91 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 92 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 93 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 94 NETHERLANDS E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 95 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 96 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 97 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 98 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 99 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 100 BELGIUM E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 101 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 102 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2021-2030 (USD MILLION)
TABLE 103 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2021-2030 (USD MILLION)
TABLE 104 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE, 2021-2030 (USD MILLION)
TABLE 105 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE, 2021-2030 (USD MILLION)
TABLE 106 SWITZERLAND E-CLINICAL SOLUTIONS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 107 REST OF EUROPE E-CLINICAL SOLUTIONS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 EUROPE E-CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 2 EUROPE E-CLINICAL SOLUTIONS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE E-CLINICAL SOLUTIONS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE E-CLINICAL SOLUTIONS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE E-CLINICAL SOLUTIONS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE E-CLINICAL SOLUTIONS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE E-CLINICAL SOLUTIONS MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 EUROPE E-CLINICAL SOLUTIONS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE E-CLINICAL SOLUTIONS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE E- CLINICAL SOLUTIONS MARKET: SEGMENTATION
FIGURE 11 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS AS WELL AS INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE, IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE E- CLINICAL SOLUTIONS MARKET FROM 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE E-CLINICAL SOLUTIONS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE E-CLINICAL SOLUTIONS MARKET
FIGURE 14 EUROPE E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2022
FIGURE 15 EUROPE E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 EUROPE E-CLINICAL SOLUTIONS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 EUROPE E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2022
FIGURE 19 EUROPE E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, CAGR (2023-2030)
FIGURE 21 EUROPE E-CLINICAL SOLUTIONS MARKET: BY DELIVERY MODE, LIFELINE CURVE
FIGURE 22 EUROPE E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2022
FIGURE 23 EUROPE E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, CAGR (2023-2030)
FIGURE 25 EUROPE E-CLINICAL SOLUTIONS MARKET: BY CLINICAL TRIAL PHASE, LIFELINE CURVE
FIGURE 26 EUROPE E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2022
FIGURE 27 EUROPE E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, CAGR (2023-2030)
FIGURE 29 EUROPE E-CLINICAL SOLUTIONS MARKET: BY ORGANIZATION SIZE, LIFELINE CURVE
FIGURE 30 EUROPE E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2022
FIGURE 31 EUROPE E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, CAGR (2023-2030)
FIGURE 33 EUROPE E-CLINICAL SOLUTIONS MARKET: BY USER DEVICE, LIFELINE CURVE
FIGURE 34 EUROPE E-CLINICAL SOLUTIONS MARKET: BY END USER, 2022
FIGURE 35 EUROPE E-CLINICAL SOLUTIONS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 EUROPE E-CLINICAL SOLUTIONS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 EUROPE E-CLINICAL SOLUTIONS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 EUROPE E-CLINICAL SOLUTIONS MARKET: SNAPSHOT (2022)
FIGURE 39 EUROPE E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022)
FIGURE 40 EUROPE E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 EUROPE E-CLINICAL SOLUTIONS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 EUROPE E-CLINICAL SOLUTIONS MARKET: PRODUCT (2023-2030)
FIGURE 43 EUROPE E-CLINICAL SOLUTIONS MARKET: COMPANY SHARE 2022 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
